Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Glutamate Receptor Ionotropic NMDA 2B Market Growth 2022-2028

  • LP 4930029
  • 96 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Glutamate Receptor Ionotropic NMDA 2B will have significant change from previous year. According to our (LP Information) latest study, the global Glutamate Receptor Ionotropic NMDA 2B market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Glutamate Receptor Ionotropic NMDA 2B market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Glutamate Receptor Ionotropic NMDA 2B market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Glutamate Receptor Ionotropic NMDA 2B market, reaching US$ million by the year 2028. As for the Europe Glutamate Receptor Ionotropic NMDA 2B landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Glutamate Receptor Ionotropic NMDA 2B players cover BioCrea GmbH, Bristol-Myers Squibb Company, Cerecor Inc., and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Glutamate Receptor Ionotropic NMDA 2B market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

JNJ-0808

Neu-2000

NP-10679

NP-11948

Radiprodil

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Acute Ischemic Stroke

Autism

Brain Ischemia

Burns

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

BioCrea GmbH

Bristol-Myers Squibb Company

Cerecor Inc.

Johnson & Johnson

Luc Therapeutics, Inc.

NeurOp, Inc

Novartis AG

UCB S.A.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Glutamate Receptor Ionotropic NMDA 2B by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Glutamate Receptor Ionotropic NMDA 2B by Country/Region, 2017, 2022 & 2028

2.2 Glutamate Receptor Ionotropic NMDA 2B Segment by Type

2.2.1 JNJ-0808

2.2.2 Neu-2000

2.2.3 NP-10679

2.2.4 NP-11948

2.2.5 Radiprodil

2.2.6 Others

2.3 Glutamate Receptor Ionotropic NMDA 2B Sales by Type

2.3.1 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)

2.3.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue and Market Share by Type (2017-2022)

2.3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Type (2017-2022)

2.4 Glutamate Receptor Ionotropic NMDA 2B Segment by Application

2.4.1 Acute Ischemic Stroke

2.4.2 Autism

2.4.3 Brain Ischemia

2.4.4 Burns

2.4.5 Others

2.5 Glutamate Receptor Ionotropic NMDA 2B Sales by Application

2.5.1 Global Glutamate Receptor Ionotropic NMDA 2B Sale Market Share by Application (2017-2022)

2.5.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue and Market Share by Application (2017-2022)

2.5.3 Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Application (2017-2022)

3 Global Glutamate Receptor Ionotropic NMDA 2B by Company

3.1 Global Glutamate Receptor Ionotropic NMDA 2B Breakdown Data by Company

3.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales by Company (2020-2022)

3.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Company (2020-2022)

3.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue by Company (2020-2022)

3.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Company (2020-2022)

3.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Company (2020-2022)

3.3 Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Company

3.4 Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Product Location Distribution

3.4.2 Players Glutamate Receptor Ionotropic NMDA 2B Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Glutamate Receptor Ionotropic NMDA 2B by Geographic Region

4.1 World Historic Glutamate Receptor Ionotropic NMDA 2B Market Size by Geographic Region (2017-2022)

4.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue by Geographic Region

4.2 World Historic Glutamate Receptor Ionotropic NMDA 2B Market Size by Country/Region (2017-2022)

4.2.1 Global Glutamate Receptor Ionotropic NMDA 2B Annual Sales by Country/Region (2017-2022)

4.2.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue by Country/Region

4.3 Americas Glutamate Receptor Ionotropic NMDA 2B Sales Growth

4.4 APAC Glutamate Receptor Ionotropic NMDA 2B Sales Growth

4.5 Europe Glutamate Receptor Ionotropic NMDA 2B Sales Growth

4.6 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Growth

5 Americas

5.1 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Country

5.1.1 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022)

5.1.2 Americas Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022)

5.2 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Type

5.3 Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Region

6.1.1 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2017-2022)

6.1.2 APAC Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2022)

6.2 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Type

6.3 APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Glutamate Receptor Ionotropic NMDA 2B by Country

7.1.1 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022)

7.1.2 Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022)

7.2 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type

7.3 Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B by Country

8.1.1 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022)

8.1.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022)

8.2 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type

8.3 Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B

10.3 Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B

10.4 Industry Chain Structure of Glutamate Receptor Ionotropic NMDA 2B

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Glutamate Receptor Ionotropic NMDA 2B Distributors

11.3 Glutamate Receptor Ionotropic NMDA 2B Customer

12 World Forecast Review for Glutamate Receptor Ionotropic NMDA 2B by Geographic Region

12.1 Global Glutamate Receptor Ionotropic NMDA 2B Market Size Forecast by Region

12.1.1 Global Glutamate Receptor Ionotropic NMDA 2B Forecast by Region (2023-2028)

12.1.2 Global Glutamate Receptor Ionotropic NMDA 2B Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Glutamate Receptor Ionotropic NMDA 2B Forecast by Type

12.7 Global Glutamate Receptor Ionotropic NMDA 2B Forecast by Application

13 Key Players Analysis

13.1 BioCrea GmbH

13.1.1 BioCrea GmbH Company Information

13.1.2 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.1.3 BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 BioCrea GmbH Main Business Overview

13.1.5 BioCrea GmbH Latest Developments

13.2 Bristol-Myers Squibb Company

13.2.1 Bristol-Myers Squibb Company Company Information

13.2.2 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.2.3 Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bristol-Myers Squibb Company Main Business Overview

13.2.5 Bristol-Myers Squibb Company Latest Developments

13.3 Cerecor Inc.

13.3.1 Cerecor Inc. Company Information

13.3.2 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.3.3 Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Cerecor Inc. Main Business Overview

13.3.5 Cerecor Inc. Latest Developments

13.4 Johnson & Johnson

13.4.1 Johnson & Johnson Company Information

13.4.2 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.4.3 Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Johnson & Johnson Main Business Overview

13.4.5 Johnson & Johnson Latest Developments

13.5 Luc Therapeutics, Inc.

13.5.1 Luc Therapeutics, Inc. Company Information

13.5.2 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.5.3 Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Luc Therapeutics, Inc. Main Business Overview

13.5.5 Luc Therapeutics, Inc. Latest Developments

13.6 NeurOp, Inc

13.6.1 NeurOp, Inc Company Information

13.6.2 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.6.3 NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 NeurOp, Inc Main Business Overview

13.6.5 NeurOp, Inc Latest Developments

13.7 Novartis AG

13.7.1 Novartis AG Company Information

13.7.2 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.7.3 Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Novartis AG Main Business Overview

13.7.5 Novartis AG Latest Developments

13.8 UCB S.A.

13.8.1 UCB S.A. Company Information

13.8.2 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Offered

13.8.3 UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 UCB S.A. Main Business Overview

13.8.5 UCB S.A. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Glutamate Receptor Ionotropic NMDA 2B Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Glutamate Receptor Ionotropic NMDA 2B Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of JNJ-0808

Table 4. Major Players of Neu-2000

Table 5. Major Players of NP-10679

Table 6. Major Players of NP-11948

Table 7. Major Players of Radiprodil

Table 8. Major Players of Others

Table 9. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)

Table 11. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Type (2017-2022) & ($ million)

Table 12. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2017-2022)

Table 13. Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)

Table 16. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Application (2017-2022)

Table 17. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application (2017-2022)

Table 18. Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Company (2020-2022)

Table 21. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Company (2020-2022)

Table 23. Global Glutamate Receptor Ionotropic NMDA 2B Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Glutamate Receptor Ionotropic NMDA 2B Producing Area Distribution and Sales Area

Table 25. Players Glutamate Receptor Ionotropic NMDA 2B Products Offered

Table 26. Glutamate Receptor Ionotropic NMDA 2B Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Geographic Region (2017-2022)

Table 31. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Glutamate Receptor Ionotropic NMDA 2B Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country/Region (2017-2022)

Table 35. Global Glutamate Receptor Ionotropic NMDA 2B Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2022)

Table 39. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2022)

Table 41. Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)

Table 43. Americas Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)

Table 45. APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2022)

Table 47. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Region (2017-2022)

Table 49. APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)

Table 51. APAC Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)

Table 53. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2022)

Table 55. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2022)

Table 57. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)

Table 59. Europe Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Glutamate Receptor Ionotropic NMDA 2B

Table 70. Key Market Challenges & Risks of Glutamate Receptor Ionotropic NMDA 2B

Table 71. Key Industry Trends of Glutamate Receptor Ionotropic NMDA 2B

Table 72. Glutamate Receptor Ionotropic NMDA 2B Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Glutamate Receptor Ionotropic NMDA 2B Distributors List

Table 75. Glutamate Receptor Ionotropic NMDA 2B Customer List

Table 76. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Forecast by Region

Table 78. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Glutamate Receptor Ionotropic NMDA 2B Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share Forecast by Application (2023-2028)

Table 96. BioCrea GmbH Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 97. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 98. BioCrea GmbH Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. BioCrea GmbH Main Business

Table 100. BioCrea GmbH Latest Developments

Table 101. Bristol-Myers Squibb Company Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 102. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 103. Bristol-Myers Squibb Company Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Bristol-Myers Squibb Company Main Business

Table 105. Bristol-Myers Squibb Company Latest Developments

Table 106. Cerecor Inc. Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 107. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 108. Cerecor Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. Cerecor Inc. Main Business

Table 110. Cerecor Inc. Latest Developments

Table 111. Johnson & Johnson Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 112. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 113. Johnson & Johnson Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Johnson & Johnson Main Business

Table 115. Johnson & Johnson Latest Developments

Table 116. Luc Therapeutics, Inc. Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 117. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 118. Luc Therapeutics, Inc. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. Luc Therapeutics, Inc. Main Business

Table 120. Luc Therapeutics, Inc. Latest Developments

Table 121. NeurOp, Inc Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 122. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 123. NeurOp, Inc Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. NeurOp, Inc Main Business

Table 125. NeurOp, Inc Latest Developments

Table 126. Novartis AG Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 127. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 128. Novartis AG Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Novartis AG Main Business

Table 130. Novartis AG Latest Developments

Table 131. UCB S.A. Basic Information, Glutamate Receptor Ionotropic NMDA 2B Manufacturing Base, Sales Area and Its Competitors

Table 132. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Product Offered

Table 133. UCB S.A. Glutamate Receptor Ionotropic NMDA 2B Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. UCB S.A. Main Business

Table 135. UCB S.A. Latest Developments

List of Figures

Figure 1. Picture of Glutamate Receptor Ionotropic NMDA 2B

Figure 2. Glutamate Receptor Ionotropic NMDA 2B Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Glutamate Receptor Ionotropic NMDA 2B Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Glutamate Receptor Ionotropic NMDA 2B Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of JNJ-0808

Figure 10. Product Picture of Neu-2000

Figure 11. Product Picture of NP-10679

Figure 12. Product Picture of NP-11948

Figure 13. Product Picture of Radiprodil

Figure 14. Product Picture of Others

Figure 15. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Type in 2021

Figure 16. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Type (2017-2022)

Figure 17. Glutamate Receptor Ionotropic NMDA 2B Consumed in Acute Ischemic Stroke

Figure 18. Global Glutamate Receptor Ionotropic NMDA 2B Market: Acute Ischemic Stroke (2017-2022) & (K Pcs)

Figure 19. Glutamate Receptor Ionotropic NMDA 2B Consumed in Autism

Figure 20. Global Glutamate Receptor Ionotropic NMDA 2B Market: Autism (2017-2022) & (K Pcs)

Figure 21. Glutamate Receptor Ionotropic NMDA 2B Consumed in Brain Ischemia

Figure 22. Global Glutamate Receptor Ionotropic NMDA 2B Market: Brain Ischemia (2017-2022) & (K Pcs)

Figure 23. Glutamate Receptor Ionotropic NMDA 2B Consumed in Burns

Figure 24. Global Glutamate Receptor Ionotropic NMDA 2B Market: Burns (2017-2022) & (K Pcs)

Figure 25. Glutamate Receptor Ionotropic NMDA 2B Consumed in Others

Figure 26. Global Glutamate Receptor Ionotropic NMDA 2B Market: Others (2017-2022) & (K Pcs)

Figure 27. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Application (2017-2022)

Figure 28. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Application in 2021

Figure 29. Glutamate Receptor Ionotropic NMDA 2B Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Company in 2021

Figure 31. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Geographic Region in 2021

Figure 33. Global Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region (2017-2022)

Figure 34. Global Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country/Region in 2021

Figure 35. Americas Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)

Figure 36. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)

Figure 37. APAC Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)

Figure 38. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)

Figure 39. Europe Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)

Figure 40. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales 2017-2022 (K Pcs)

Figure 42. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue 2017-2022 ($ Millions)

Figure 43. Americas Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country in 2021

Figure 44. Americas Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country in 2021

Figure 45. United States Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Region in 2021

Figure 50. APAC Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Regions in 2021

Figure 51. China Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country in 2021

Figure 58. Europe Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country in 2021

Figure 59. Germany Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Market Share by Country in 2021

Figure 66. Egypt Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Glutamate Receptor Ionotropic NMDA 2B Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Glutamate Receptor Ionotropic NMDA 2B in 2021

Figure 72. Manufacturing Process Analysis of Glutamate Receptor Ionotropic NMDA 2B

Figure 73. Industry Chain Structure of Glutamate Receptor Ionotropic NMDA 2B

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390